Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.
Laukhtina E, Abufaraj M, Al-Ani A, Ali MR, Mori K, Moschini M, Quhal F, Sari Motlagh R, Pradere B, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Fajkovic H, Soria F, Enikeev D, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Laukhtina E, et al. Among authors: katayama s. Eur Urol Focus. 2022 Mar;8(2):447-456. doi: 10.1016/j.euf.2021.03.016. Epub 2021 Mar 21. Eur Urol Focus. 2022. PMID: 33762203 Free article. Review.
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review.
Laukhtina E, Pradere B, Mori K, Schuettfort VM, Quhal F, Mostafaei H, Sari Motlangh R, Katayama S, Grossmann NC, Moschini M, Enikeev D, Shariat SF; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Laukhtina E, et al. Among authors: katayama s. Urol Oncol. 2021 Mar;39(3):180-190. doi: 10.1016/j.urolonc.2020.12.019. Epub 2021 Jan 8. Urol Oncol. 2021. PMID: 33423937 Free article.
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets.
Grossmann NC, Schuettfort VM, Pradere B, Moschini M, Quhal F, Mostafaei H, Soria F, Katayama S, Laukhtina E, Mori K, Sari Motlagh R, Poyet C, Abufaraj M, Karakiewicz PI, Shariat SF, D'Andrea D. Grossmann NC, et al. Among authors: katayama s. Onco Targets Ther. 2021 Jan 13;14:315-324. doi: 10.2147/OTT.S242248. eCollection 2021. Onco Targets Ther. 2021. PMID: 33488094 Free PMC article. Review.
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
Mori K, Resch I, Miura N, Laukhtina E, Schuettfort VM, Pradere B, Katayama S, D'Andrea D, Kardoust Parizi M, Abufaraj M, Fukuokaya W, Collà Ruvolo C, Luzzago S, Knipper S, Palumbo C, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Egawa S, Shariat SF. Mori K, et al. Among authors: katayama s. Cancer Immunol Immunother. 2021 Sep;70(9):2641-2650. doi: 10.1007/s00262-021-02884-w. Epub 2021 Feb 16. Cancer Immunol Immunother. 2021. PMID: 33591412 Free PMC article.
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. Schuettfort VM, et al. Among authors: katayama s. BJU Int. 2022 Feb;129(2):182-193. doi: 10.1111/bju.15379. Epub 2021 Apr 7. BJU Int. 2022. PMID: 33650265 Free PMC article. Clinical Trial.
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials.
Sari Motlagh R, Mori K, Laukhtina E, Aydh A, Katayama S, Grossmann NC, Mostafai H, Pradere B, Quhal F, Schuettfort VM, Roshandel MR, Karakiewicz PI, Teoh J, Shariat SF, Fajkovic H. Sari Motlagh R, et al. Among authors: katayama s. BJU Int. 2021 Sep;128(3):280-289. doi: 10.1111/bju.15383. Epub 2021 May 3. BJU Int. 2021. PMID: 33683778 Free PMC article.
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy.
Rajwa P, Schuettfort VM, Quhal F, Mori K, Katayama S, Laukhtina E, Pradere B, Motlagh RS, Mostafaei H, Grossmann NC, Aulitzky A, Paradysz A, Karakiewicz PI, Fajkovic H, Zimmermann K, Heidenreich A, Gontero P, Shariat SF. Rajwa P, et al. Among authors: katayama s. World J Urol. 2021 Oct;39(10):3771-3779. doi: 10.1007/s00345-021-03715-4. Epub 2021 May 17. World J Urol. 2021. PMID: 33997919 Free PMC article.
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review.
Laukhtina E, Sari Motlagh R, Mori K, Quhal F, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Ploussard G, Karakiewicz PI, Briganti A, Abufaraj M, Enikeev D, Pradere B, Shariat SF. Laukhtina E, et al. Among authors: katayama s. World J Urol. 2021 Nov;39(11):4085-4099. doi: 10.1007/s00345-021-03703-8. Epub 2021 May 28. World J Urol. 2021. PMID: 34047825 Free PMC article.
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
Katayama S, Mori K, Schuettfort VM, Pradere B, Mostafaei H, Quhal F, Rajwa P, Motlagh RS, Laukhtina E, Moschini M, Grossmann NC, Araki M, Teoh JY, Rouprêt M, Margulis V, Enikeev D, Karakiewicz PI, Abufaraj M, Compérat E, Nasu Y, Shariat SF. Katayama S, et al. Eur Urol Focus. 2022 May;8(3):761-768. doi: 10.1016/j.euf.2021.05.002. Epub 2021 May 27. Eur Urol Focus. 2022. PMID: 34053904 Free article. Review.
The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer.
Quhal F, Rajwa P, Mori K, Laukhtina E, Grossmann NC, Schuettfort VM, König F, Aydh A, Motlagh RS, Katayama S, Mostafai H, Pradere B, Marra G, Gontero P, Mathieu R, Karakiewicz PI, Briganti A, Shariat SF, Heidenreich A. Quhal F, et al. Among authors: katayama s. Prostate. 2021 Aug;81(11):765-771. doi: 10.1002/pros.24173. Epub 2021 May 31. Prostate. 2021. PMID: 34057227 Free PMC article.
1,350 results